Shakeri A, Adanty C. Romosozumab (sclerostin monoclonal antibody) for the treatment of osteoporosis in postmenopausal women: A review. J Popl Ther Clin Pharmacol. 2020;27(1):e25-e31. doi:10.15586/jptcp.v27i1.655